Document:

famg_ex108.htm

EXHIBIT 10.8
 
ADDENDUM TO THE INTELLECTUAL PROPERTY 
ASSIGNMENT AGREEMENT SIGNED ON OCTOBER 27TH, 2014 
 
B E T W E E N:
 
HATEM ESSADDAM, chemist, domiciled and residing at 24, Saint-Stanislas street, in the city of Sainte-Thérèse, province of Québec, J7E 3M7, acting both personally and for a corporation to be incorporated;
 
(the "Assignor")
 
-and-
 
LOOP HOLDINGS, INC., a corporation incorporated under the federal laws of Nevada having its head office at 1999 Avenue of the Stars, Suite 2520, in the city of Los Angeles, province of California, herein represented by its president, Daniel Solomita, duly authorized as he so declares;
 
(the "Assignee")
 
-and-
 
DANIEL SOLOMITA, businessman, domiciled and residing at 98, Val d'Ajol blvd, in the city of Lorraine, province of Quebec, J62 3Z6;
 
(the "Intervenor")
 
	WHEREAS	the above mentioned parties have signed an Intellectual Property Assignment Agreement on October 27th, 2014 (hereinafter the "Agreement");

		
	WHEREAS,	since the signature of the Agreement, the above mentioned parties have declared themselves satisfied and/or have waived all conditions necessary to proceed to the closing of the Agreement;

		
	WHEREAS,	since the signature of the Agreement, the Assignor has proceeded to the incorporation of 9319-7218 Québec Inc. and has transferred to said corporation all his rights, titles and interests (including all Intellectual Property rights) present and future in and to the Technique;

 
	 
	1

	

	 

 
	WHEREAS, 	according to paragraph 2.2c) of the Agreement, part of the Purchase Price is payable once the Plant developed by the Assignee reaches certain Milestones;

		
	WHEREAS, 	according to paragraph 2.4 of the Agreement, Royalties are payable by the Assignee to the Assignor;

		
	WHEREAS 	the Plant will in fact be operated by 8198381 Canada Inc.;

 
THE PARTIES TO THE PRESENT AGREE:
 
		1. 	The preamble shall form an integral part of the present addendum;

			
		2. 	The present paragraph 1.1(cc) of the Agreement is hereby deleted in its entirety and is replaced with the following:

			
	 
	 
	"Plant" has the meaning ascribed thereto in the Recitals, being understood that it includes any facility built, owned or used by the Assignee and/or by its subsidiaries or Person under its control and/or by 8198381 Canada Inc., that is used for any process of depolymerisation of the polyethylene terephthalate based on the Technique;

	 
	 
	 

	 
	3.
	Capitalized terms used but not otherwise defined in this addendum shall have the meanings given to them in the Agreement;

 
[Signature page follows]
 
	 
	2

	

	 

 
DATED April 10th, 2015.
 
 
	/s/ Hatem Essaddam
	 
	/s/ Daniel Solomita
	 

	HATEM ESSADDAM, acting
	 
	LOOP HOLDINGS, INC.
	 

	Personally and on behalf of
	 
	The Assignee
	 

	9319-7218 Québec Inc. 
	 
	By: Daniel Solomita
	 

	The Assignor 
	 
	Title: President
	 

	 
	 
	 
	 

	 
	 
	 
	 

	/s/ Daniel Solomita
	 
	 
	 

	DANIEL SOLOMITA 
	 
	 
	 

	The Intervenor 
	 
	 
	 

 
 
 
3famg_ex109.htm

EXHIBIT 10.9
 
ASSIGNMENT AND MORAL RIGHTS WAIVER
 
	TO: 	LOOP HOLDINGS INC. (the "Assignee")

	 
	  

	RE:  
	Intellectual Property Assignment Agreement between Hatem Essaddam, 9319-7218 Québec Inc. (the "Assignor"), the Assignee, and Daniel Solomita dated as of October 27, 2014 (the "Assignment Agrheement").

 
Capitalized terms used but not otherwise defined in this Certificate shall have the meanings given to them in the Assignment Agreement.
 
WHEREAS pursuant to section 5.1.7 of the Assignment Agreement, the undersigned have agreed to assign the Intellectual Property Rights and waive any moral rights they have therein;
 
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are acknowledged by each of the undersigned: 
 
	1. 	Each of the undersigned hereby irrevocably sells, assigns and transfers to the Assignee, its successors and assigns, in perpetuity, throughout the world, all of undersigned's right, title and interest, in and to theIntellectual Property Rights, including copyright and any and all other right, title, interest, privileges, benefits and causes of action, including without limitation any ownership of and title to the Intellectual Property Rights in all tangible forms, which undersigned now has or hereafter may acquire with respect to the Intellectual Property Rights.

		 
	2. 	Each of the undersigned hereby represents and warrants that:

 
		(a) 	He or it has the full right, power and authority to make and perform this agreement;

			 
		(b) 	Neither has granted any rights to any third parties which would interfere with the rights granted to the Assignee;

			 
		(c) 	Each of the undersigned will perform and cause to be performed such further and other acts, and execute and deliver, or cause to be executed and delivered, such further and other documents as the Assignee considers necessary or desirable to carry out the terms and intent of this assignment agreement; and

			 
		(d) 	Each of the undersigned shall upon request of the Assignee forthwith deliver to Assignee, or as the Assignee shall direct, all tangible forms of the Intellectual Property Rights in the possession, or under the control of, the undersigned.

 
	3. 	Each of the undersigned hereby waives on a perpetual, irrevocable and worldwide basis any and all author's or moral rights and equivalent rights in foreign jurisdictions, in and to the Intellectual Property Rights, which waiver may be invoked, without limitation, by the Assignee, any person authorized by the Assignee to use the Intellectual Property Rights, and any subsequent assignees.

 
[Signature page follows]   

 
	 
	1

	

	 

 
IN WITNESS WHEREOF this certificate has been executed the 1st day of April, 2015.
 
	 
	9319-7218 QUÉBEC INC.	 

	 	 	  	 
		By:	/s/ Hatem Essaddam
	 

	 
	Name:
	Hatem Essaddam	 

	 
	Title:
		 

	 
	 
	  
	 

	 
	By:
	/s/ Hatem Essaddam
	 

	 
	Name:
	HATEM ESSADDAM
	 

 
 
 
Assignment and Waiver of Moral Rights

 
2Exhibit 10.1
    

    

    

    

    

    
      October 29, 2015
    

    
      Nabil:
    

    
      On behalf of the Board of Directors of
      DGSE Companies, Inc. (the “Board”), I am pleased to offer you the
      positions of Chief Financial Officer and Secretary of the Board at DGSE
      Companies, Inc.  This position will report directly to the Chief
      Executive Officer.
    

    
      The Board would like to extend to you the
      following compensation and benefits, beginning on your effective date,
      November 5, 2015:
    

    	
        Salary:
        Annual gross starting salary of $225,000, paid in biweekly
        installments by your choice of check or direct deposit
      
	
        Performance Bonus:
        Up to twenty-five percent (25%) of your annual gross salary based on
        achievement of goals, annually agreed upon by the Board.
      
	
        Equity: Participation
        in any equity compensation grants for senior management, commensurate
        with what other members of senior management receive
      
	
        Benefits:
        You will continue to be entitled to participate in all DGSE benefit
        plans for which you are eligible. While the plans offered may change
        from time to time during your employment we currently offer the
        following:
      

    
      Vacation: 20 days per year
401(k):
      Available the 90 days following initial employment date
Health
      Insurance: Blue Cross Blue Shield
Dental
      Insurance: Met Life
Life
      and Disability Insurance: MetLife
Short
      and Long Term Disability
Sick
      leave

    

    
      Accepting this offer of employment, you
      certify your understanding that your employment will be on an at-will
      basis, and that neither you, the Board, any shareholders, nor any third
      party has entered into any other contract regarding the terms or
      duration of your employment. As an at-will employee, either you or DGSE
      will be free to terminate your employment with the company at any time,
      with or without cause or advance notice. We look forward to your
      continued success at DGSE and are confident that you will continue to
      play a critical role in our company’s future.
    

    
      If you have any questions, please feel
      free to contact me at 972-587-4023.
    

    
      Sincerely,

Matthew
      Peakes
Chief
      Executive Officer
    

    

    

    
      
        

        

      

      
        

        

        
          

        

      

      
        

        

      

    

    
      Accept Job Offer
By
      signing and dating this letter below, I, Nabil J. Lopez, accept this job
      offer of Chief Financial Officer and Secretary of the Board, by DGSE
      Companies, Inc.

Signature:____/s/
      NABIL J. LOPEZ___________________________
      Date:___10/29/15__________
    

    

    

    
      Decline Job Offer
By
      signing and dating this letter below, I, Nabil J. Lopez, decline this
      job offer of Chief Financial Officer and Secretary of the Board, by DGSE
      Companies, Inc.

Signature:_________________________________
      Date:_____________Exhibit

Exhibit 10.1

Amendment No. 5
to the Edwards Lifesciences Corporation 401(k)
Savings and Investment Plan
September 1, 2015

The Edwards Lifesciences Corporation 401(k) Savings and Investment Plan ("Plan") as amended and restated as of January 1, 2009 is amended effective September 1, 2015, unless specified otherwise:

1. Section 2.42 is amended in its entirety by the following:

2.42 "Year of Vesting Service" or "Vesting Service" means the period credited to an Employee for purposes of determining the extent to which the Employee is vested in his Employer Matching Account under the vesting schedule set forth in Section 7.2. Under the Plan, an Employee is credited with a Year of Vesting Service if the Employee completes at least 1,000 Hours of Service during any Plan Year. An Employee's period of service with a corporation that becomes a Commonly Controlled Entity of an Employer shall be taken into account for purposes of this Section if the Employee is employed on the date the corporation becomes a Commonly Controlled Entity. An individual who became an Employee on September 1, 2015 who immediately prior to such date was a leased employee of TriNet HR Corporation working at the location(s) of CardiAQ Valve Technologies, Inc. shall have their service at CardiAQ Valve Technologies, Inc. taken into account for purposes of this Section.  An individual who became an Employee on December 20, 2007 who immediately prior to such date was an employee of CardioVations Division of Ethicon shall have their service with CardioVations Division of Ethicon taken into account for purposes of this Section.  Credit shall be given at the rate of 45 Hours of Service for each week during such period (but not to exceed 1,000 Hours of Service for any twelve month period). If an Employee is credited with at least one Year of Vesting Service, he shall never lose such service regardless of when he returns to employment as an Employee. Notwithstanding the foregoing, an individual (i) who immediately prior to the Effective Date was employed by Baxter or a Commonly Controlled Entity of Baxter and (ii) who becomes an Eligible Employee on the Effective Date shall be credited with the number of Years of Vesting Services such individual earned while employed with Baxter or a Commonly Controlled Entity of Baxter.

IN WITNESS WHEREOF, a duly authorized officer of the Company has caused this Plan to be executed on the 15th day of September, 2015.

	
			
	 
	EDWARDS LIFESCIENCES CORPORATION

	 
	 

	 
	 

	 
	By:
	/s/ Christine McCauley

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}]]